H.C. Wainwright Starts Acasti Pharma (ACST) at Buy

December 16, 2022 6:31 AM UTC Send to a Friend
(Updated - December 16, 2022 6:32 AM EST)

H.C. Wainwright analyst Oren Livnat initiates coverage on Acasti Pharma (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login